However, it is unlikely that this level of lifestyle counselling would be considered consistent with WHO and NICE guidelines on GLP-1 RA obesity therapy [17,18], as it appears more as an adjunct to the medication rather than the other way around. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.